Introducing way more signals! We've added more signal sources to capture the full customer journey.

Learn More!
Tiltan Pharma

Tiltan Pharma

Tiltan Pharma Ltd. is a biotechnology company dedicated to the development and commercialization of its proprietary anti-angiogenic platform for the treatment of cancer and other indications. The Company is jointly owned by Yissum, the Technology Transfer Company of the Hebrew University, its entrepreneurs, Israeli investors and a group of Canadian investors.

Last updated on

About Tiltan Pharma

Founded

2006

Estimated Revenue

$1M-$10M

Employees

11-50

Funding / Mkt. Cap

$2M

Category

Sector

Health Care

Industry Group

Pharmaceuticals, Biotechnology & Life Sciences

Industry

Pharmaceuticals

SIC Code

28

NAICs Code

32541

Location

City

Jerusalem

State

Jerusalem

Country

Israel
Tiltan Pharma

Tiltan Pharma

Find your buyer within Tiltan Pharma

Tech Stack (0)

search